Weill David

Insider profile

Performance

Overall performance
2.9

Performance over holding periods
4.2
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 46% 68% 82%
Transactions
9 11% Buy
34 71% Buy
47 69% Buy
Performance for realised trades
4.4
Average return 109%
Success rate 73%
Average holding period 220
Transactions 28
Weill David's trades of Transmedics Group Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-06 2026-03-04 S Sale
89,958 -30.1%
479.41
US$1,722,623
89,958 -30.1% 479.41 US$1,722,623
2026-03-04 2026-03-04 PrS Proposed sale
94,198
281.06
US$3,471,487
94,198 281.06 US$3,471,487
2025-12-05 2025-12-03 S Sale
72,673 -1.7%
79.31
US$553,812
72,673 -1.7% 79.31 US$553,812
2025-12-03 2025-12-03 PrS Proposed sale
5,000
138.64
US$693,210
5,000 138.64 US$693,210
2025-05-23 2025-05-23 PrS Proposed sale
732
123.88
US$90,683
732 123.88 US$90,683
2025-05-23 2025-05-23 S Sale
732 -5.7%
123.88
US$90,680
732 -5.7% 123.88 US$90,680
2024-05-31 2024-05-29 S Sale
1,193 -10.0%
141.65
US$168,988
1,193 -10.0% 141.65 US$168,988
2024-05-29 2024-05-29 PrS Proposed sale
1,193
141.65
US$168,982
1,193 141.65 US$168,982
2024-05-14 2024-05-10 S Sale
2,500 -18.3%
129.82
US$324,550
2,500 -18.3% 129.82 US$324,550
2024-05-10 2024-05-10 PrS Proposed sale
2,500
130.70
US$326,750
2,500 130.70 US$326,750
2023-08-30 2023-08-29 B Purchase
2,500 +22.3%
62.00
US$155,000
2,500 +22.3% 62.00 US$155,000
2023-02-28 2023-02-27 S Sale
4,970 -33.2%
76.51
US$380,255
4,970 -33.2% 76.51 US$380,255
2023-02-28 2023-02-27 S Sale
964 -6.0%
77.64
US$74,845
964 -6.0% 77.64 US$74,845
2022-11-14 2022-11-10 S Sale
21,645 -61.6%
56.00
US$1,212,120
21,645 -61.6% 56.00 US$1,212,120